Understanding and overcoming barriers to malaria control in Asia-Pacific
Official title: Understanding and Targeting the Barriers to Effective Malaria Control and Elimination in the Asia-Pacific Region
Funded at Walter and Eliza Hall Inst Medical Res · NIH-11421417 · Data updated 2026-11-12
This grant supports field and lab work to find practical ways to reduce malaria transmission in Asia-Pacific communities, including Cambodia and Papua New Guinea.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Walter and Eliza Hall Inst Medical Res NIH-funded |
| Lab location | 1 site (Parkville, AUSTRALIA) |
| Project start | April 28, 2017 |
| Project end | March 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $156,330 |
| NIH project number | 5U19AI129392-11 |
| Project ID | NIH-11421417 on NIH RePORTER |
Who could benefit from this research
✓Could help
Residents of malaria-endemic areas in Cambodia and Papua New Guinea, and others in similar transmission settings, who participate in surveillance and intervention activities.
✕Less likely to help
Individuals not exposed to malaria or not participating in surveillance or intervention activities may not benefit directly.
What this research studies
Researchers will run coordinated field, lab, and modeling activities across sites with different malaria transmission levels. They will improve surveillance and response by combining traditional methods with targeted surveys to catch asymptomatic infections. The project aims to identify locally effective intervention mixes to cut transmission, including new tools and approaches to reach people who are hard to reach or underserved. Results could inform better use of scarce resources to move toward malaria elimination in the region.
Why it matters
Potential benefit: If successful, the work could lead to smarter malaria control strategies that reduce illness and save lives in the Asia-Pacific.
How similar studies have gone: Previous regional studies have shown that integrated surveillance and targeted interventions can reduce transmission, though challenges remain for vivax malaria.
Where this research is happening
-
Walter and Eliza Hall Inst Medical Res
Parkville, Australia Active
Researchers
- Principal investigator: Mueller, Ivo J — Walter and Eliza Hall Inst Medical Res
- Study coordinator: Mueller, Ivo J
Related research
Other NIH-funded projects on the same topics.
-
Digital malaria surveillance in Ethiopia to improve outbreak detection
A collaboration to add a malaria-specific digital module to an existing surveillance system in Africa to help detect and respond to outbreaks faster.
-
Cross-sector partnership uses digital malaria surveillance in Ethiopia
A US-based team will adapt and test a digital malaria surveillance module in SORMAS to help detect and respond to malaria outbreaks in Ethiopia.
-
Malaria control project in Western Kenya to reduce illness and deaths
A large, multi-year effort in western Kenya will help track malaria spread and test ways to prevent transmission so fewer people get sick or die.
-
Optimizing tafenoquine dose to prevent relapse of vivax malaria in Asia
A study tests the best tafenoquine dose to prevent P. vivax malaria relapse in people in East Asia and Oceania.
-
Optimizing tafenoquine dose to prevent P. vivax malaria relapses in Asia
A study to find the best single-dose tafenoquine amount to prevent relapse of P. vivax malaria in people in East Asia and Oceania.
-
Severe malaria and brain risk in children
This grant studies how severe malaria in young children can affect brain development and long-term thinking and behavior, with a focus on kids in Uganda.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.